Clinical Trial Update: Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye [Phase 4]

View source ↗

Summary

This clinical trial update reports on the efficacy of 0.28% sodium hyaluronate eye drops for moderate to severe dry eye in a Phase 4 study; the trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• 0.28% Sodium Hyaluronate Eye Drops (sodium hyaluronate)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Dry Eye Disease (DED), Tear Break-Up Time | Phase 4 | Status: ENROLLING_BY_INVITATION